| Valiant Laboratories Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
543998
ISIN Demat:
INE0JWS01017
Book Value(₹): 58.15 NSE Symbol:
VALIANTLAB
Div & Yield(%):
N.A
Market Cap(₹ Cr): 500.49 P/E(TTM): N.A
EPS(TTM): N.A
Face Value(₹): 10.00 |
| Particulars | Mar 2025 (₹ Cr) | Dec 2024 (₹ Cr) | Sep 2024 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 57.77 | 35.23 | 21.48 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 57.77 | 35.23 | 21.48 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | 0.65 | 0.67 | 1.93 |
| Total Income | 58.42 | 35.89 | 23.41 |
| Total Expenditure | 53.94 | 34.60 | 28.22 |
| PBIDT | 4.48 | 1.29 | -4.81 |
| Interest | 0.05 | 0.06 | 0.01 |
| PBDT | 4.43 | 1.23 | -4.81 |
| Depreciation | 0.51 | 0.51 | 0.51 |
| Tax | 0.06 | 0.00 | -0.09 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.63 | -0.88 | 0.75 |
| Reported Profit After Tax | 3.24 | 1.60 | -5.98 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.24 | 1.60 | -5.98 |
| EPS (Unit Curr.) | 0.74 | 0.37 | -1.39 |
| EPS (Adj) (Unit Curr.) | 0.69 | 0.34 | -1.29 |
| Calculated EPS (Unit Curr.) | 0.75 | 0.37 | -1.38 |
| Calculated EPS (Adj) (Unit Curr.) | 0.70 | 0.34 | -1.28 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.98 | 1.47 | -5.51 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.77 | 1.36 | -5.11 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Equity | 43.45 | 43.45 | 43.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 7.75 | 3.66 | -22.39 |
| PBDTM(%) | 7.67 | 3.49 | -22.39 |
| PATM(%) | 5.61 | 4.54 | -27.84 |
